News

2023

• 06/28/2023: The Grover Lab presents new research at ISTH in Montreal

• 06/17/2023: Steven Grover presents at the Massachusetts General Hospital Center for Hematology seminar series

• 05/11/2023: Our recent publication on C1 inhibitor deficiency and thrombosis has been highlighted in an editorial by David Gailani

• 05/05/2023: Steven Grover presents at the 13th C1-inhibitor Deficiency & Angioedema Workshop in Budapest, Hungary

• 04/03/2023: The Grover Lab publishes on the association between plasma C1 inhibitor levels and venous thromboembolism  in JTH

• 03/22/2023: Steven Grover presents at the inaugural Immunothrombosis Symposium in Munich, Germany hosted by the LMU Center for Advanced Sciences

• 02/08/2023: The Grover Lab's ASH Plenary highlighted in the Hematologist

• 01/30/2023: Our recent Blood paper has been highlighted in Hematopoiesis News and Rare Disease Advisor

• 01/26/2023: Grover Lab publishes on enhanced coagulation and venous thrombosis associated with  C1 inhibitor deficiency in mice in Blood

2022

• 12/31/2022: 12/31/2022: Grover Lab publishes on application of a new whole blood thrombin generation assay in Blood Advances

• 12/30/2022: Steven Grover awarded UNC Junior Faculty Development Award

• 12/12/2022:  ASH Plenary presentation featured in ASH News Daily and Hem Onc Today

• 09/16/2022: Grover Lab research selected for presentation in the Plenary Scientific Session at the 64th Annual Meeting of the ASH

• 09/14/2022: Grover Lab research on Hereditary Angioedema and risk of venous thromboembolism highlighted by Rare Research Advisor

• 09/13/2022: Steven Grover presents to the Division of Hematology at the UNC School of Medicine on the role of the intrinsic pathway of coagulation in venous thrombosis.

• 9/01/2022: Paper on association between Hereditary Angioedema and Venous Thromboembolism published in the Journal of Thrombosis and Haemostasis.